microRNA-155 Regulates the Generation of Immunoglobulin Class-Switched Plasma Cells

microRNA-155 (miR-155) is expressed by cells of the immune system after activation and has been shown to be required for antibody production after vaccination with attenuated Salmonella. Here we show the intrinsic requirement for miR-155 in B cell responses to thymus-dependent and -independent antig...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Immunity (Cambridge, Mass.) Mass.), 2007-12, Vol.27 (6), p.847-859
Hauptverfasser: Vigorito, Elena, Perks, Kerry L., Abreu-Goodger, Cei, Bunting, Sam, Xiang, Zou, Kohlhaas, Susan, Das, Partha P., Miska, Eric A., Rodriguez, Antony, Bradley, Allan, Smith, Kenneth G.C., Rada, Cristina, Enright, Anton J., Toellner, Kai-Michael, MacLennan, Ian C.M., Turner, Martin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:microRNA-155 (miR-155) is expressed by cells of the immune system after activation and has been shown to be required for antibody production after vaccination with attenuated Salmonella. Here we show the intrinsic requirement for miR-155 in B cell responses to thymus-dependent and -independent antigens. B cells lacking miR-155 generated reduced extrafollicular and germinal center responses and failed to produce high-affinity IgG1 antibodies. Gene-expression profiling of activated B cells indicated that miR-155 regulates an array of genes with diverse function, many of which are predicted targets of miR-155. The transcription factor Pu.1 is validated as a direct target of miR155-mediated inhibition. When Pu.1 is overexpressed in wild-type B cells, fewer IgG1 cells are produced, indicating that loss of Pu.1 regulation is a contributing factor to the miR-155-deficient phenotype. Our results implicate post-transcriptional regulation of gene expression for establishing the terminal differentiation program of B cells.
ISSN:1074-7613
1097-4180
DOI:10.1016/j.immuni.2007.10.009